CONTEXT: Sex steroids play a central role in breast cancer development. OBJECTIVE: This study aimed to relate polymorphic variants in 36 candidate genes in the sex steroid pathway to serum concentrations of sex steroid hormones and SHBG. DESIGN: Data on 700 genetic polymorphisms were combined with existing hormone assays and data on breast cancer incidence, within the European Prospective Investigation into Cancer and Nutrition (EPIC) and the Nurses' Health Study (NHS) cohorts; significant findings were reanalyzed in the Multiethnic Cohort (MEC). SETTING AND PARTICIPANTS: We analyzed data from a pooled sample of 3852 pre- and postmenopausal Caucasian women from EPIC and NHS and 454 postmenopausal women from MEC. MAIN OUTCOME MEASURES: Outcome measures were SHBG, testosterone, dehydroepiandrosterone (DHEAS), androstenedione, estrone (E1), and estradiol (E2) as well as breast cancer risk. RESULTS: Globally significant associations were found among pre- and postmenopausal women combined between levels of SHBG and the SHBG gene and between DHEAS and the FSHR and AKR1C3 genes. Among postmenopausal women, serum E1 and E2 were significantly associated with the genes CYP19 and FSHR, and E1 was associated with ESR1. None of the variants related to serum hormone levels showed any significant association with breast cancer risk. CONCLUSIONS: We confirmed associations between serum levels of SHBG and the SHBG gene and of E1 and E2 and the CYP19 and ESR1 genes. Novel associations were observed between FSHR and DHEAS, E1, and E2 and between AKR1C3 and DHEAS.
CONTEXT: Sex steroids play a central role in breast cancer development. OBJECTIVE: This study aimed to relate polymorphic variants in 36 candidate genes in the sex steroid pathway to serum concentrations of sex steroid hormones and SHBG. DESIGN: Data on 700 genetic polymorphisms were combined with existing hormone assays and data on breast cancer incidence, within the European Prospective Investigation into Cancer and Nutrition (EPIC) and the Nurses' Health Study (NHS) cohorts; significant findings were reanalyzed in the Multiethnic Cohort (MEC). SETTING AND PARTICIPANTS: We analyzed data from a pooled sample of 3852 pre- and postmenopausal Caucasian women from EPIC and NHS and 454 postmenopausal women from MEC. MAIN OUTCOME MEASURES: Outcome measures were SHBG, testosterone, dehydroepiandrosterone (DHEAS), androstenedione, estrone (E1), and estradiol (E2) as well as breast cancer risk. RESULTS: Globally significant associations were found among pre- and postmenopausal women combined between levels of SHBG and the SHBG gene and between DHEAS and the FSHR and AKR1C3 genes. Among postmenopausal women, serum E1 and E2 were significantly associated with the genes CYP19 and FSHR, and E1 was associated with ESR1. None of the variants related to serum hormone levels showed any significant association with breast cancer risk. CONCLUSIONS: We confirmed associations between serum levels of SHBG and the SHBG gene and of E1 and E2 and the CYP19 and ESR1 genes. Novel associations were observed between FSHR and DHEAS, E1, and E2 and between AKR1C3 and DHEAS.
Authors: P Muti; M Trevisan; A Micheli; V Krogh; G Bolelli; R Sciajno; F Berrino Journal: Cancer Epidemiol Biomarkers Prev Date: 1996-11 Impact factor: 4.254
Authors: L N Kolonel; B E Henderson; J H Hankin; A M Nomura; L R Wilkens; M C Pike; D O Stram; K R Monroe; M E Earle; F S Nagamine Journal: Am J Epidemiol Date: 2000-02-15 Impact factor: 4.897
Authors: Christy G Woolcott; Yurii B Shvetsov; Frank Z Stanczyk; Lynne R Wilkens; Kami K White; Christian Caberto; Brian E Henderson; Loïc Le Marchand; Laurence N Kolonel; Marc T Goodman Journal: Endocr Relat Cancer Date: 2010-02-18 Impact factor: 5.678
Authors: B Han; S Li; D Song; D Poisson-Paré; G Liu; V Luu-The; J Ouellet; S Li; F Labrie; G Pelletier Journal: J Steroid Biochem Mol Biol Date: 2008-10-19 Impact factor: 4.292
Authors: Alison M Dunning; Mitch Dowsett; Catherine S Healey; Louise Tee; Robert N Luben; Elizabeth Folkerd; Karen L Novik; Livia Kelemen; Saeko Ogata; Paul D P Pharoah; Douglas F Easton; N E Day; Bruce A J Ponder Journal: J Natl Cancer Inst Date: 2004-06-16 Impact factor: 13.506
Authors: Christopher A Haiman; Daniel O Stram; Malcolm C Pike; Laurence N Kolonel; Noel P Burtt; David Altshuler; Joel Hirschhorn; Brian E Henderson Journal: Hum Mol Genet Date: 2003-08-27 Impact factor: 6.150
Authors: Alison M Dunning; Catherine S Healey; Caroline Baynes; Ana-Teresa Maia; Serena Scollen; Ana Vega; Raquel Rodríguez; Nuno L Barbosa-Morais; Bruce A J Ponder; Yen-Ling Low; Sheila Bingham; Christopher A Haiman; Loic Le Marchand; Annegien Broeks; Marjanka K Schmidt; John Hopper; Melissa Southey; Matthias W Beckmann; Peter A Fasching; Julian Peto; Nichola Johnson; Stig E Bojesen; Børge Nordestgaard; Roger L Milne; Javier Benitez; Ute Hamann; Yon Ko; Rita K Schmutzler; Barbara Burwinkel; Peter Schürmann; Thilo Dörk; Tuomas Heikkinen; Heli Nevanlinna; Annika Lindblom; Sara Margolin; Arto Mannermaa; Veli-Matti Kosma; Xiaoqing Chen; Amanda Spurdle; Jenny Change-Claude; Dieter Flesch-Janys; Fergus J Couch; Janet E Olson; Gianluca Severi; Laura Baglietto; Anne-Lise Børresen-Dale; Vessela Kristensen; David J Hunter; Susan E Hankinson; Peter Devilee; Maaike Vreeswijk; Jolanta Lissowska; Louise Brinton; Jianjun Liu; Per Hall; Daehee Kang; Keun-Young Yoo; Chen-Yang Shen; Jyh-Cherng Yu; Hoda Anton-Culver; Argyrios Ziogoas; Alice Sigurdson; Jeff Struewing; Douglas F Easton; Montserrat Garcia-Closas; Manjeet K Humphreys; Jonathan Morrison; Paul D P Pharoah; Karen A Pooley; Georgia Chenevix-Trench Journal: Hum Mol Genet Date: 2009-01-06 Impact factor: 6.150
Authors: Deborah J Thompson; Catherine S Healey; Caroline Baynes; Bolot Kalmyrzaev; Shahana Ahmed; Mitch Dowsett; Elizabeth Folkerd; Robert N Luben; David Cox; Dennis Ballinger; Paul D P Pharoah; Bruce A J Ponder; Alison M Dunning; Douglas F Easton Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-12 Impact factor: 4.254
Authors: Tanda M Dudenkov; James N Ingle; Aman U Buzdar; Mark E Robson; Michiaki Kubo; Irada Ibrahim-Zada; Anthony Batzler; Gregory D Jenkins; Tracy L Pietrzak; Erin E Carlson; Poulami Barman; Matthew P Goetz; Donald W Northfelt; Alvaro Moreno-Aspita; Clark V Williard; Krishna R Kalari; Yusuke Nakamura; Liewei Wang; Richard M Weinshilboum Journal: Breast Cancer Res Treat Date: 2017-04-20 Impact factor: 4.872
Authors: Eva Lundin; Isaac Wirgin; Annekatrin Lukanova; Yelena Afanasyeva; Vittorio Krogh; Tomas Axelsson; Kari Hemminki; Tess V Clendenen; Alan A Arslan; Nina Ohlson; Sabina Sieri; Nirmal Roy; Karen L Koenig; Annika Idahl; Franco Berrino; Paolo Toniolo; Göran Hallmans; Asta Försti; Paola Muti; Per Lenner; Roy E Shore; Anne Zeleniuch-Jacquotte Journal: Cancer Epidemiol Date: 2012-05-25 Impact factor: 2.984
Authors: Kerryn W Reding; Chu Chen; Kimberly Lowe; David R Doody; Christopher S Carlson; Christina T Chen; John Houck; Linda K Weiss; Polly A Marchbanks; Leslie Bernstein; Robert Spirtas; Jill A McDonald; Brian L Strom; Ronald T Burkman; Michael S Simon; Jonathan M Liff; Janet R Daling; Kathleen E Malone Journal: Cancer Causes Control Date: 2012-03-15 Impact factor: 2.506
Authors: Huiru Chang; Song Yao; David Tritchler; Meredith A Hullar; Johanna W Lampe; Lilian U Thompson; Susan E McCann Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-02 Impact factor: 4.254
Authors: Steven C Moore; Charles E Matthews; Xiao Ou Shu; Kai Yu; Mitchell H Gail; Xia Xu; Bu-Tian Ji; Wong-Ho Chow; Qiuyin Cai; Honglan Li; Gong Yang; David Ruggieri; Jennifer Boyd-Morin; Nathaniel Rothman; Robert N Hoover; Yu-Tang Gao; Wei Zheng; Regina G Ziegler Journal: J Natl Cancer Inst Date: 2016-05-18 Impact factor: 13.506
Authors: Stephanie D Boone; Kathy B Baumgartner; Richard N Baumgartner; Avonne E Connor; Christina M Pinkston; Shesh N Rai; Elizabeth C Riley; Lisa M Hines; Anna R Giuliano; Esther M John; Mariana C Stern; Gabriela Torres-Mejía; Roger K Wolff; Martha L Slattery Journal: Cancer Causes Control Date: 2014-08-05 Impact factor: 2.506
Authors: Stephen A Haddad; Kathryn L Lunetta; Edward A Ruiz-Narváez; Jeannette T Bensen; Chi-Chen Hong; Lara E Sucheston-Campbell; Song Yao; Elisa V Bandera; Lynn Rosenberg; Christopher A Haiman; Melissa A Troester; Christine B Ambrosone; Julie R Palmer Journal: Breast Cancer Res Treat Date: 2015-10-12 Impact factor: 4.872
Authors: William Rosner; Susan E Hankinson; Patrick M Sluss; Hubert W Vesper; Margaret E Wierman Journal: J Clin Endocrinol Metab Date: 2013-03-05 Impact factor: 5.958
Authors: Tess Clendenen; Anne Zeleniuch-Jacquotte; Isaac Wirgin; Karen L Koenig; Yelena Afanasyeva; Eva Lundin; Alan A Arslan; Tomas Axelsson; Asta Försti; Göran Hallmans; Kari Hemminki; Per Lenner; Nirmal Roy; Roy E Shore; Yu Chen Journal: PLoS One Date: 2013-07-23 Impact factor: 3.240
Authors: Jennifer H Lin; Marc J Gunter; JoAnn E Manson; Kathryn M Rexrode; Nancy R Cook; Peter Kraft; Barbara B Cochrane; Rowan T Chlebowski; Gloria Y F Ho; Shumin M Zhang Journal: PLoS One Date: 2012-07-25 Impact factor: 3.240